Vr-Adviser

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
37
Total Value
1175247364
Accession Number
0001415889-25-013093
Form Type
13F-HR
Manager Name
Vr-Adviser
Data Enrichment
89% identified
33 identified4 unidentified

Holdings

37 positions
Manager:
Search and click to pin securities to the top
Page 2 of 2
Solid Biosciences Inc.
Shares:2.5M
Value:$9.2M
Savara Inc
Shares:3.3M
Value:$9.0M
Abivax S.A.
Shares:1.3M
Value:$8.4M
G70077105
Shares:750.0K
Value:$7.7M
Surrozen, Inc./DE
Shares:632.9K
Value:$7.4M
Zura Bio Ltd
Shares:5.0M
Value:$6.5M
Artiva Biotherapeutics, Inc.
Shares:1.6M
Value:$4.8M
Trevi Therapeutics, Inc.
Shares:615.5K
Value:$3.9M
Applied Therapeutics, Inc.
Shares:5.6M
Value:$2.7M
4D Molecular Therapeutics, Inc.
Shares:677.6K
Value:$2.2M
G1933S101
Shares:987.3K
Value:$2.1M
TENAX THERAPEUTICS, INC.
Shares:208.3K
Value:$1.4M
Mersana Therapeutics, Inc.
Shares:3.6M
Value:$1.2M
Century Therapeutics, Inc.
Shares:2.5M
Value:$1.2M
Tenaya Therapeutics, Inc.
Shares:1.6M
Value:$886.8K
GLYCOMIMETICS INC
Shares:3.0M
Value:$630.0K
Instil Bio, Inc.
Shares:33.2K
Value:$576.0K